Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression ; volume:38 ; number:1 ; day:15 ; month:4 ; year:2019 ; pages:1-11 ; date:12.2019
Journal of experimental & clinical cancer research ; 38, Heft 1 (15.4.2019), 1-11, 12.2019
- Urheber
-
Jin, Hua
Jang, Yoonjeong
Cheng, Nian
Li, Qing
Cui, Peng-Fei
Zhou, Zhi-Wei
Jiang, Hu-Lin
Cho, Myung-Haing
Westover, Kenneth D.
Tan, Qun-You
Xu, Cheng-Xiong
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-019-1170-7
- URN
-
urn:nbn:de:101:1-2019051016070914327679
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
03.01.2025, 10:01 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jin, Hua
- Jang, Yoonjeong
- Cheng, Nian
- Li, Qing
- Cui, Peng-Fei
- Zhou, Zhi-Wei
- Jiang, Hu-Lin
- Cho, Myung-Haing
- Westover, Kenneth D.
- Tan, Qun-You
- Xu, Cheng-Xiong
- SpringerLink (Online service)
Ähnliche Objekte (12)
Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP
Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer
Target Mutant KRAS with Molecular Glue
K-Ras protein as a drug target
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
A pan-KRAS degrader for the treatment of KRAS-mutant cancers
A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers
Targeting ErbB receptors in a three-dimensional cell culture model of K-Ras mutant colorectal cancer
Current therapy of KRAS-mutant lung cancer
Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP
Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer
Target Mutant KRAS with Molecular Glue
K-Ras protein as a drug target
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
A pan-KRAS degrader for the treatment of KRAS-mutant cancers
A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers
Targeting ErbB receptors in a three-dimensional cell culture model of K-Ras mutant colorectal cancer
Current therapy of KRAS-mutant lung cancer
Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP
Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer
Target Mutant KRAS with Molecular Glue
K-Ras protein as a drug target
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
A pan-KRAS degrader for the treatment of KRAS-mutant cancers
A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers
Targeting ErbB receptors in a three-dimensional cell culture model of K-Ras mutant colorectal cancer